Pt Articles & Analysis
63 news found
Jon Greenwald will present on Tuesday, March 7, 2023, from 3:30 - 3:55 p.m. PT. Caira management will also be available for one-on-one meetings throughout the conference and AAOS from Tuesday, March 7 – Friday, March 10. ...
PhD, Valo’s CEO and founder is scheduled to present on Tuesday, January 10, 2023, at 2:30 PM PT (5:30 PM ET) in the Golden Gate Room (31st Fl) at the Westin St. ...
Morgan Healthcare Conference on Wednesday, January 11, 2023, at 1:30 p.m. PT/4:30 p.m. ET. "Being part of the JPM healthcare community for the second year in a row is very exciting to us as a growing team and organization. ...
Presentation Details: Piper Sandler 34th Annual Healthcare Conference Format: Fireside Chat Date: Wednesday, November 30, 2022 Time: 10:30 a.m. ET / 7:30 a.m. PT Location: New York The JMP Securities Hematology and Oncology Summit Format: Fireside Chat Date: Tuesday, December 6, 2022 Time: 3:40 p.m. ET / 12:40 p.m. PT Location: Virtual The presentations will ...
Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in a fireside chat at the 34th Annual Piper Sandler Healthcare Conference in New York on Wednesday, November 30, 2022, at 11:30 AM PT / 2:30 PM ET. A live and archived webcast of the presentation ...
” The topline findings of the GRADUATE I and II studies will be presented at the upcoming Clinical Trials on Alzheimer’s Disease (CTAD) Conference on Wednesday, November 30, 2022 at 16:15 PT. In September 2000, MorphoSys entered into a global collaboration agreement with Roche. ...
” Program sessions featuring Elucid’s technology include: “Solving the Heart Attack Crisis with a Next-Generation Plaque Analysis Tool” Saturday, November 5, 2022, at 12:00 PT CT, Health Innovation Pavilion, Heart Hub Speaker: Todd Villines, MD, Elucid “Pioneering a New Approach to More Accurately Predict Heart Attack and Stroke” ...
ByElucid
Presentation Details: Credit Suisse 31st Annual Healthcare Conference Format: Presentation Date: Wednesday, November 9, 2022 Time: 11:35 a.m. ET / 8:35 a.m. PT Location: Rancho Palos Verdes, CA Jefferies London Healthcare Conference Format: Presentation Date: Thursday, November 17, 2022 Time: 12:55 p.m. GMT / 7:55 a.m. ET / 4:55 a.m. PT Location: London The ...
ClotTriever also resulted in significantly fewer patients with post-thrombotic syndrome (PTS), with an absolute reduction of 13% at 30 days. "Preventing PTS is the goal of DVT treatment," said Dr. ...
Clinical data demonstrating initial safety and efficacy from the RESKUE trial are being presented by Chief Medical Officer Maria Escolar, M.D., at the 29th Congress of European Society of Gene & Cell Therapy (ESGCT), October 11-14, 2022 Subjects treated with FBX-101 have shown increased galactocerebrosidase (GALC) enzyme activity in plasma and cerebrospinal fluid (CSF), normal white matter ...
” Friday, October 7th at 10:10-11:10 AM PT (1:10-2:10 PM ET) 1x1 Meetings: Management will be available for one-on-one meetings October 6th & 7th The panel presentation will be available only to conference participants and will not be webcast. ...
(Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that Bill Newell, Chief Executive Officer, will present at the 2022 Wells Fargo Healthcare Conference on Friday, September 9, 2022, at 10:25 a.m. ET / 7:25 a.m. PT in Boston. The presentation will be accessible ...
The poster presentation, titled, "Inducing complete and long-lasting tumor eradications of a nectin-4 ADC generated with a novel linker technology,” will be given on September 7, 2022, at 5:45 p.m. PT during the conference’s scientific poster session. Presentation highlights: Araris’ anti-Nectin-4 antibody-drug conjugate (ADC) showed superior activity to ...
“PTS is a debilitating condition with symptoms including swelling, difficulty walking, skin changes and poorly healing open wounds. Research has shown PTS quality of life scores can be as low as those of patients suffering from heart failure or cancer. ...
(Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that Bill Newell, Chief Executive Officer, will present at the 2022 Wedbush PacGrow Healthcare Conference’s panel discussion, “ADCs – Take Me to Your Tumor” on Wednesday, August 10, 2022, at 2:20 p.m. ET / 11:20 ...
Management is scheduled to present on Wednesday, August 10, 2022, at 1:00 PM PT / 4:00 PM ET. A live and archived webcast of the presentation will be available on “Investors” section of the Pulmonx website at. ...
“We are beyond excited to get to work with our patient, guiding them through the training process as they learn to use this device to live more independently and, most importantly, communicate with their family and friends,” said David Putrino, PhD, PT, Director of Rehabilitation Innovation for the Mount Sinai Health System and a Principal Investigator of the COMMAND ...
ISPRM 2022 is now over | International Society of Physical and Rehabilitation Medicine | Lisbon PT After 4 nice days and some smart presentations, ISPRM 2022 now ends with great memories. ...
Life after Knee Replacement “The day after the procedure, they had me taking a little stroll and walking stairs. I started PT right away after I got home,” recalls Art. Within a couple of months after the surgery, Art was feeling as he had before he had knee pain. ...
(Nasdaq: VAXX), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today announced that Mei Mei Hu, President and Chief Executive Officer of Vaxxinity, will participate in a fireside chat at the Bank of America Securities 2022 Healthcare Conference, being held in Las Vegas, Nevada on Thursday, May 12, 2022 at 10:40 a.m. PT. A live webcast of ...
ByVaxxinit